# Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/suppressed-recurrent-bladder-cancer-after-androgen-suppression-with-androgen/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masaki Shiota,Keijiro Kiyoshima,Akira Yokomizo,Ario Takeuchi,Eiji Kashiwagi,Takashi Dejima,Ryosuke Takahashi,Junichi Inokuchi,Katsunori Tatsugami,Masatoshi Eto |
| Citations | 70 |
| DOI | 10.1016/j.juro.2016.08.006 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2503810307 |
| PMID | 27506696 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Katsunori Tatsugami](https://scholariq.org/researchers/katsunori-tatsugami/)

## Paper journal

- [The Journal of Urology](https://scholariq.org/journals/the-journal-of-urology/)

## Paper primary topic

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Paper topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.